Peripheral absolute neutrophil count (ANC) >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3; obtained within 14 days prior to study entryXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXWithin 6 weeks prior to randomization: Absolute neutrophil count (ANC) must be >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXRe-registration: ANC >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3 must be obtained =< 7 days prior to protocol registrationXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXWithin 2 weeks prior to registration: Absolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3 within 4 weeks prior to randomizationXx_NEWLINE_xXWithin 60 days prior to registration on study: Absolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXWithin 14 days of registration: Absolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 obtained =< 21 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3, within 21 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,200 cells/mm^3, within 21 days prior to study entryXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (=< 28 days prior to registration)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/mm^3 obtained within 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (1.5 x 10^9/L) must be met within 28 days of cycle 1 day 1 (C1D1)Xx_NEWLINE_xXINCLUSION CRITERIA FOR SECOND-LINE THERAPY: Absolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXINCLUSION CRITERIA FOR THIRD-LINE THERAPY: Absolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3 andXx_NEWLINE_xXAbsolute neutrophil >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1,500/mm3;Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) > 1,500/ÂµLXx_NEWLINE_xXAbsolute neutrophil count > 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/mm^3Xx_NEWLINE_xXENROLLMENT TO THE DOSE ESCALATION, EXPANSION AND PART II: Absolute neutrophil count >= 1,500 mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 or >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3 within 14 days of enrollment to trialXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3 before starting therapyXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3 obtained within 30 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1000 cells/mm^3 (1.0 x 10^9/L) at least 3 weeks prior to screening unless attributable to disease; ANC > 500 cells/mm^3 is permissible if due to diseaseXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count > 1,000 cells/mm^3 (1.0 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 cells/?L,Xx_NEWLINE_xXAbsolute neutrophil count >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/mm^3Xx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute granulocyte count >= 1,500/mm^3 (1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC): >= 750/mm^3, must be at least 7days after last dose of growth factorXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5K/mm^3Xx_NEWLINE_xXAbsolute neutrophil >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 750/mm^3Xx_NEWLINE_xXCOHORT 1: HORMONE RECEPTOR POSITIVE BREAST CANCER: Absolute neutrophil (ANC) >= 1,500/mm^3 (>= 1.5 X10^6/L)Xx_NEWLINE_xXCOHORT 2: TRIPLE NEGATIVE BREAST CANCER: Absolute neutrophil (ANC) >= 1,500/mm^3 (>= 1.5 X 10^6/L)Xx_NEWLINE_xXCOHORT 3: ENDOMETRIAL CANCER: Absolute neutrophil (ANC) >= 1,500/mm^3 (>= 1.5 X 10^6/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 750 cells/mm^3 within 90 days prior to randomizationXx_NEWLINE_xXObtained within 28 days prior to registration: absolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 k/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3, at the time of enrollmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3 without growth factors within 1 week of the initiation of treatmentXx_NEWLINE_xXAbsolute neutrophil count > 1.5 x 10^9 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >1,500 /mm3;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXWithin 14 days prior to cycle 1 day 1 of treatment: Absolute neutrophil count (ANC) >= 1,000 K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 cells/mm3cellsXx_NEWLINE_xXWithin 4 weeks prior to the registration: absolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXWithin 28 days prior to registration for protocol therapy: Absolute neutrophil count (ANC) >= 1,500 K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3 OR >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 2000 cells/mm^3Xx_NEWLINE_xXPerformed within 14 days (+ 3 working days) prior to registration: Absolute neutrophil count (ANC) > 1,500/mm^3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/cu mmXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500 cell/mm3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil (ANC) >= 1,500/mm^3 (>= 1.5 X 10^6/L)Xx_NEWLINE_xXAbsolute neutrophil count > 750 cells/mm^3 (1.0 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500 cells/mm^3Xx_NEWLINE_xXObtained within 14 days prior to registration; absolute neutrophil count (ANC) ?1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 cells/mm^3Xx_NEWLINE_xXWithin 60 days prior to registration, hematologic minimal values: absolute neutrophil count > 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 500/mlXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 K/mm^3 (must be stable off any growth factor within 4 weeks of first study drug administration)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/L (1,500/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1800/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 X K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 K/cu mm; for subjects with ANC < 1.0 K/cu mm due to significant marrow involvement by MCL, ANC must be > .5 K/cu mmXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXPRIOR TO LYMPHODEPLETION: Absolute neutrophil count (ANC) is > 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXCAPMATINIB INCLUSION CRITERIA: Absolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXREGORAFENIB INCLUSION CRITERIA: Absolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3 without growth factors within 1 week of the initiation of treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count > 100 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 K/cu mmXx_NEWLINE_xXAn absolute neutrophil count (ANC) > 1,000/mm^3 (patients who have bone marrow infiltration by MCL are eligible if their ANC is >= 500/mm^3 [growth factor allowed]; these patients should be discussed with either the principal investigator [PI] or Co-PI of the study for final approval)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/mm^3Xx_NEWLINE_xXGranulocyte count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) 550/cu mm (off myeloid growth factors)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3 without growth factor supportXx_NEWLINE_xXAbsolute neutrophil count >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/microliterXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXTREATMENT: Engrafted post-transplant (absolute neutrophil count [ANC] > 500 for at least 3 consecutive days) and ANC > 500 at the time of infusionXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3 (system international [SI] units 1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXb. Absolute neutrophil count (ANC) ? 1,500/ÂµLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3, within 14 days prior to study entryXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXPatients should have an absolute neutrophil count (ANC) of > 500?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >=1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute peripheral neutrophil count (ANC) of >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count < 1,500 cells/mm3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (repeat if more than 3 days before the first dose)Xx_NEWLINE_xXAbsolute neutrophils >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5K/mm^3Xx_NEWLINE_xXabsolute neutrophil count greater than or equal to 1,500 cells/microliterXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1,500/mm3Xx_NEWLINE_xXWithin 14 days prior to randomization: Absolute neutrophil count (ANC) must be >= 1200/mm^3Xx_NEWLINE_xXAdequate neutrophils (defined as absolute neutrophil count >= 1,500/mm^3).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3, within 28 days of day 0.Xx_NEWLINE_xXWithin 14 days of study registration: Absolute lymphocyte count: >= 500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1 K/cu mmXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (without transfusion or growth factor support)Xx_NEWLINE_xXObtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXANC (absolute neutrophil count) is 1,500Xx_NEWLINE_xXBlood counts performed within 3 weeks prior to starting study therapy must have absolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/mm^3Xx_NEWLINE_xXAbsolute lymphocyte count >= 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 per mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count > 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) must be >= 1200/mm^3 within 28 days before randomizationXx_NEWLINE_xXWithin 14 days prior to step 1 registration: Absolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC): >= 1,500 /mm^3Xx_NEWLINE_xXAbsolute lymphocyte count >= 500/mm^3Xx_NEWLINE_xXObtained within 30 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXObtained =< 7 days prior to registration: Absolute neutrophil count (ANC) >= 1700/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) < 1,500/ÂµLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count: >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count less than 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 or >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3, within 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) must be > 750/mm^3 (not achieved by transfusion)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) must be >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXGranulocyte count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 500Xx_NEWLINE_xXAbsolute granulocyte count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXPHASE II: Absolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count of >= 1,500 or cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXGranulocytes/absolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3 for 5 days after recovery from ASCT nadirXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 within four weeks prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than 500/ÂµL.Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) at least 1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/ mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1,500 /mLXx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count > 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count > 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 (1.5 x 10^9/L) (unless due to marrow involvement) obtained within 4 weeks prior to registrationXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/ mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0/mm^3, ANC >= 0.5/mm^3 (if patient has baseline neutropenia due to lymphoma)Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1400/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXObtained within 14 weeks prior to registration on study: absolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000 cells/mm^3.Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1.0/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500/mm^3; (patients who have bone marrow infiltration by MCL are eligible if their ANC is >= 1000/mm^3 [growth factor not allowed] or their platelet level is >= 50,000/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) count >= 1,500/mm^3Xx_NEWLINE_xXGranulocyte count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil counts >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) =< 500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil counts (ANC) >= 1,500cells/mm^2Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3 within 30 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count > 1,000 cells/mm^3 (1.0 x 10^9/L), if neutropenia is due to bone marrow involvement absolute neutrophil count must be >= 500 cells/mm^3 (0.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3 (unsupported)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1.0/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000/mm^3Xx_NEWLINE_xXSTEP 2 ENROLLMENT AND RANDOMIZATION: absolute neutrophil count (ANC) >= 1,500/mm^3 within 3 weeks of study entryXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,250/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXPatients who have had count recovery (absolute neutrophil count [ANC] > 500,000/mm^3; non transfused platelet count over 30,000/mm^3) and are at least 30 days after induction and/or transplantation but no more than 120 days post transplantXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,500 (growth factors permitted)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3 obtained =< 14 days prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXEXPANSION COHORT ONLY: Absolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count > 750 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 /mm^3Xx_NEWLINE_xXANC >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 500/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) < 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,800 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,200 cells/mm^3Xx_NEWLINE_xXWithin 8 weeks of randomization: Absolute neutrophil counts >= 1,500 cell/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 750 cells/mm^3 (0.75 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 750/mm^3Xx_NEWLINE_xXAbsolute granulocyte count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 500/mm^3Xx_NEWLINE_xXAbsolute granulocyte count >= 500/mm^3Xx_NEWLINE_xXSubjects with an absolute neutrophil count (ANC) >500/?L at Screening.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3 (unsupported)Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXHematological: absolute neutrophil count (ANC) > 1,500 cells/mm^3, platelet > 100,000 cells/mm^3, hemoglobin > 9.0 g/dLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/m^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count: >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000/mm^3; (patients who have bone marrow infiltration by MCL are eligible if their ANC is 500/mm^3 [growth factor allowed] or their platelet level is equal to or > than 30,000/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1,500/microLXx_NEWLINE_xXAbsolute neutrophil count (ANC) of >= 500/?LXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) <1,500/?LXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 2,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) <1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,500/mm3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500/ÂµL (without growth factors)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,500 per mm3Xx_NEWLINE_xXAbsolute neutrophil count > 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,500 per mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500/ÂµLXx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count of > 1,500 cell/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >1,500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) =< 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXabsolute lymphocyte count > 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1200/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3 (International System of Units [SI] units 1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1000/mm^3 unless deemed likely related to lymphoma involvement in the bone marrow where the minimum ANC allowable will be 500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,100 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/?L unless due to marrow involvement by lymphomaXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/mm^3Xx_NEWLINE_xXParticipants with an absolute neutrophil count (ANC) < 500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500 cells/LXx_NEWLINE_xXAbsolute neutrophil counts (ANC) ? 1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 500 cells/mm^3 (0.5 x 10^9/L); growth factor allowed to achieveXx_NEWLINE_xXAbsolute neutrophil count: >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 750/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 K/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,500 x10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count: >= 750/mm^3 within 90 days before enrollmentXx_NEWLINE_xXNeutrophils (absolute neutrophil count [ANC]) >= 1,500/microliterXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3Xx_NEWLINE_xXRequired prior to infusion of ATLCAR.CD30 cells: Absolute neutrophil count (ANC) >= 500 cells/mm^3 for 3 consecutive daysXx_NEWLINE_xXTotal neutrophil count > 1,500/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) > 500/?l and platelet count >50,000/?lXx_NEWLINE_xXAbsolute neutrophil count >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 750 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3, obtained within 14 days prior to C11-AMT PET scanXx_NEWLINE_xXNeutrophil count > 1,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 K/cu mmXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 K/cu mmXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000 cells/mm^3 without transfusion support > 7 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 500/?l and platelets ? 20000/?l (unsupported by transfusions).Xx_NEWLINE_xXAbsolute neutrophil count < 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count > 1,500 cells/mm^3*Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3, performed within 28 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,500/mm^3Xx_NEWLINE_xX